ypN0: Does It Matter How You Get There? Nodal Downstaging in Esophageal Cancer

A study about different findings of PET-CT between neoadjuvant and non-neoadjuvant therapy: SUVmax is not a reliable predictor of lymphatic involvement after neoadjuvant therapy for esophageal cancer

(2016) Jae Kil Park et al.   Journal of Thoracic Disease

Neoadjuvant Treatment Response in Negative Nodes Is an Important Prognosticator After Esophagectomy

(2015) Dylan R. Nieman et al.   ANNALS OF THORACIC SURGERY

Usefulness of positron emission tomography-computed tomography in pre-operative evaluation of intra-thoracic esophageal cancer

(2015) Jae Jun Kim et al.   Thoracic Cancer

Tumor Stage After Neoadjuvant Chemotherapy Determines Survival After Surgery for Adenocarcinoma of the Esophagus and Esophagogastric Junction

(2014) Andrew R. Davies et al.   JOURNAL OF CLINICAL ONCOLOGY

Induction Therapy Does Not Improve Survival for Clinical Stage T2N0 Esophageal Cancer

(2014) Paul J. Speicher et al.   Journal of Thoracic Oncology

Diagnostic Accuracy of Lymph Node Metastasis Depends on Metabolic Activity of the Primary Lesion in Thoracic Squamous Esophageal Cancer

(2013) O. Manabe et al.   JOURNAL OF NUCLEAR MEDICINE

Refining pathological evaluation of neoadjuvant therapy for adenocarcinoma of the esophagus

(2013) Fergus Noble   WORLD JOURNAL OF GASTROENTEROLOGY

Neoadjuvant Concurrent Chemoradiotherapy for Locally Advanced Esophageal Cancer in a Single High-Volume Center

(2012) A. Zanoni et al.   ANNALS OF SURGICAL ONCOLOGY

Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

(2012) P. van Hagen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Preoperative Assessment of Tumor Location and Station-Specific Lymph Node Status in Patients with Adenocarcinoma of the Gastroesophageal Junction

(2012) Brechtje A. Grotenhuis et al.   WORLD JOURNAL OF SURGERY

Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study

(2011) D. Han et al.   DISEASES OF THE ESOPHAGUS

Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis

(2011) Katrin M Sjoquist et al.   LANCET ONCOLOGY

7th Edition of the AJCC Cancer Staging Manual: Esophagus and Esophagogastric Junction

(2010) Thomas W. Rice et al.   ANNALS OF SURGICAL ONCOLOGY

Response to induction therapy in oesophageal and cardia carcinoma using Mandard tumour regression grade or size of residual foci

(2010) G. Verlato et al.   BRITISH JOURNAL OF SURGERY

Integrated FDG-PET/CT compared with intravenous contrast-enhanced CT for evaluation of metastatic regional lymph nodes in patients with resectable early stage esophageal cancer

(2009) Masahiro Okada et al.   ANNALS OF NUCLEAR MEDICINE

Survival in Lymph Node Negative Adenocarcinoma of the Esophagus after R0 Resection With and Without Neoadjuvant Therapy: Evidence for Downstaging of N Status

(2009) Jessica M. Leers et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Comparison of endoscopic ultrasonography (EUS), positron emission tomography (PET), and computed tomography (CT) in the preoperative locoregional staging of resectable esophageal cancer

(2009) Jeongmin Choi et al.   SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES

Effect of neoadjuvant chemoradiotherapy on prognosis and surgery for esophageal carcinoma

(2009) Jin Lv et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Japanese Classification of Esophageal Cancer, tenth edition: part I

(2009)   Esophagus

Effects of neoadjuvant chemotherapy on primary tumor and lymph node metastasis in esophageal squamous cell carcinoma: additive association with prognosis

(2008) Hirofumi Akita et al.   DISEASES OF THE ESOPHAGUS